BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34572930)

  • 1. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
    Püschel J; Dubrovska A; Gorodetska I
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting aldehyde dehydrogenase for prostate cancer therapies.
    Ma M; He W; Zhao K; Xue L; Xia S; Zhang B
    Front Oncol; 2022; 12():1006340. PubMed ID: 36300093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.
    Muralikrishnan V; Hurley TD; Nephew KP
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
    Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
    Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
    Januchowski R; Wojtowicz K; Zabel M
    Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH as a Stem Cell Marker in Solid Tumors.
    Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
    Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance.
    Verma P; Shukla N; Kumari S; Ansari MS; Gautam NK; Patel GK
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188887. PubMed ID: 36997008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
    Clark DW; Palle K
    Ann Transl Med; 2016 Dec; 4(24):518. PubMed ID: 28149880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer stem cells-origin, characteristics and therapy.
    Prabavathy D; Swarnalatha Y; Ramadoss N
    Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
    Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
    Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Cell Cycle; 2011 May; 10(9):1378-84. PubMed ID: 21552008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.
    Gangavarapu KJ; Azabdaftari G; Morrison CD; Miller A; Foster BA; Huss WJ
    Stem Cell Res Ther; 2013 Oct; 4(5):132. PubMed ID: 24405526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of cancer stem cells from cultured breast cancer cells and xenografted breast tumors based on aldehyde dehydrogenase activity.
    Fernando W; Rowter D; Arun RP; Venkatesh J; Marcato P
    Methods Cell Biol; 2022; 171():111-125. PubMed ID: 35953196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study.
    Masciale V; Grisendi G; Banchelli F; D'Amico R; Maiorana A; Sighinolfi P; Stefani A; Morandi U; Dominici M; Aramini B
    Front Oncol; 2019; 9():1394. PubMed ID: 31921651
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
    Liao F; Zhang J; Hu Y; Najafabadi AH; Moon JJ; Wicha MS; Kaspo B; Whitfield J; Chang AE; Li Q
    Cancer Immunol Immunother; 2022 Aug; 71(8):1959-1973. PubMed ID: 35098344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.